Skye Bioscience, Inc.: how funds voted at the meeting of 6 Jun 2025
- Ticker
- SKYE
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 120
- Ballot items
- 4
120 filers on Form N-PX reported votes at the Skye Bioscience, Inc. meeting of 6 Jun 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Skye Bioscience, Inc. has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
6 nominees. 63.6% of the reported votes are for. 33 filers withheld from or voted against at least one nominee.
372 vote records from 37 filers. 11 of the 37 filers that marked the item voted against management.
- Positions of 21 fund families
- For 15
- Abstain or withhold 6
- Against management 6
Item 2: Advisory vote on executive pay (say-on-pay)
152 vote records from 117 filers. 64 of the 110 filers that marked the item voted against management. 7 filers gave no management mark.
- Positions of 28 fund families
- For 8
- Against 20
- Against management 20
Item 3: Frequency of the say-on-pay vote
One year: 104 filers. For: 1 filer. Against: 1 filer. Two years: 1 filer. Three years: 1 filer. Not applicable: 1 filer.
150 vote records from 114 filers. 2 of the 108 filers that marked the item voted against management. 6 filers gave no management mark.
- Positions of 28 fund families
- Split or no vote 28
Item 4: Audit-related items (auditor ratification)
62 vote records from 37 filers. 0 of the 37 filers that marked the item voted against management.
- Positions of 21 fund families
- For 21
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Pay-vote frequency | 4. Auditor |
|---|---|---|---|
| AllianceBernstein | Against, against management | Split | No report |
| BlackRock and iShares | Against, against management | Split | For |
| BNY Mellon | Against, against management | Split | No report |
| Charles Schwab | For | Split | For |
| Columbia Threadneedle | Against, against management | Split | For |
| DWS | Against, against management | Split | For |
| Equitable | Against, against management | Split | For |
| Fidelity | Against, against management | Split | For |
| Global X | Against, against management | Split | For |
| Goldman Sachs | Against, against management | Split | For |
| Guggenheim and Rydex | Against, against management | Split | For |
| Invesco | Against, against management | Split | No report |
| J.P. Morgan | Against, against management | Split | No report |
| Lincoln Financial | For | Split | For |
| Morgan Stanley, Eaton Vance and Calvert | Against, against management | Split | For |
| Nationwide | Against, against management | Split | For |
| Neuberger Berman | For | Split | No report |
| Northern Trust and FlexShares | For | Split | For |
| Nuveen and TIAA | For | Split | For |
| Pacific Life funds | Against, against management | Split | For |
| PGIM and Prudential | For | Split | No report |
| Principal | Against, against management | Split | No report |
| ProShares and ProFunds | Against, against management | Split | For |
| State Street and SPDR | For | Split | For |
| T. Rowe Price | Against, against management | Split | For |
| Vanguard | For | Split | For |
| Victory Capital | Against, against management | Split | For |
| Voya | Against, against management | Split | For |
Questions
- How many filers reported votes at the Skye Bioscience, Inc. meeting?
- 120 Form N-PX filers reported votes at the meeting of 6 Jun 2025. On say-on-pay, 64 of 110 filers that marked the item voted against management (58.2%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Skye Bioscience, Inc. reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Skye Bioscience, Inc. with a meeting date within three days of 6 Jun 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .